UNSPSC 51283505: Oxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UH95VD7V76, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but generally known as oxacillin, which bears US NIH Compound Identifier 4608. European Medicines Agency schedules Oxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09484MIG.

UNSPSC 51283505 Oxacillin, a Commodity code, shows limited recent procurement activity under its nominal scope; the state and local opportunities identified instead reflect broader pharmaceutical and medical supply procurement spanning naloxone, emergency medical consumables, generic pharmaceuticals, and OTC products rather than oxacillin specifically. State and local governments use this code tier to purchase pharmaceuticals and medical supplies for public health departments, emergency response agencies, and cooperative purchasing consortia supporting multi-jurisdictional health systems. The issuing bodies include county health departments, municipal fire departments, state health agencies, and multi-state cooperative purchasing alliances coordinating procurement across member jurisdictions.

Recent activity spans Florida, Texas, and Minnesota-based consortia. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the County Community Health Building, with a two-year initial term and one-year renewal option. The City of Tampa's Purchasing Department released IFB 26P00145 in March 2026 for medical and first aid supplies—169 line items including respiratory equipment, cardiac monitoring electrodes, airway devices, and medical consumables for the Tampa Fire Department Rescue Division, designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract amount of $700,000.00. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted RFP S1070000015802 in January 2026 to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities, with proposals due March 26, 2026 and awarded vendor availability required by May 15, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, representing early-stage market research rather than active procurement.